Post by Renata Collazo, MS, MBA
Global Business Development- Cell & Gene, mRNA, Microbial (Specialized Modalities Platform)
A great perspective on how microbial manufacturing is evolving to meet the growing demands of today's biologics market. In this Q&A, Axel Erler shares insights on increasing process complexity, the need for more flexible and scalable manufacturing platforms, and how innovation is helping accelerate development while improving efficiency and consistency.